![ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine](https://www.ccjm.org/content/ccjom/86/9/601/F1.large.jpg)
ACE inhibitors and ARBs: Managing potassium and renal function | Cleveland Clinic Journal of Medicine
![Optimizing clinical nutrition research: the role of adaptive and pragmatic trials | European Journal of Clinical Nutrition Optimizing clinical nutrition research: the role of adaptive and pragmatic trials | European Journal of Clinical Nutrition](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41430-023-01330-7/MediaObjects/41430_2023_1330_Fig4_HTML.png)
Optimizing clinical nutrition research: the role of adaptive and pragmatic trials | European Journal of Clinical Nutrition
STOP-ACEi Trial on X: "HUGE milestone for #STOPACEi trial. The 400th participant was recruited at Western HSCT today. We need just 10 more to reach target now. So close! Keep up the
![PDF] Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial | Semantic Scholar PDF] Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/04a62a79c8b2d8bb44d27f904b69b286c724e628/4-Table1-1.png)
PDF] Multicentre randomized controlled trial of angiotensin-converting enzyme inhibitor/angiotensin receptor blocker withdrawal in advanced renal disease: the STOP-ACEi trial | Semantic Scholar
![Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41440-022-00902-7/MediaObjects/41440_2022_902_Fig1_HTML.png)
Role of renin-angiotensin system blockade in advanced CKD: to use or not to use? | Hypertension Research
![Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine](https://www.thelancet.com/cms/attachment/922b8829-9aac-4da6-80dd-55845ee588d4/gr1_lrg.jpg)
Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: a prospective cohort study - eClinicalMedicine
![Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease - Kidney International Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease - Kidney International](https://www.kidney-international.org/cms/asset/0941c796-23cf-48b4-807e-555f8131ad60/ga1.jpg)
Evaluation of the stopping angiotensin converting enzyme inhibitor compared to angiotensin receptor blocker (STOP ACEi trial) in advanced and progressive chronic kidney disease - Kidney International
![A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy - ScienceDirect A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0085253821003963-fx1.jpg)
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy - ScienceDirect
![Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal](https://onlinejcf.com/cms/asset/1fa20054-4f40-4868-82be-b506eede80cb/gr2.jpg)
Rationale and Design of the Proactive-HF Trial for Managing Patients With NYHA Class III Heart Failure by Using the Combined Cordella Pulmonary Artery Sensor and the Cordella Heart Failure System - Journal
![American Society of Nephrology on X: "Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced #CKD and Risk of Adverse Outcomes https://t.co/vT7yAblwZd https://t.co/fEnirq1Wv6" / X American Society of Nephrology on X: "Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced #CKD and Risk of Adverse Outcomes https://t.co/vT7yAblwZd https://t.co/fEnirq1Wv6" / X](https://pbs.twimg.com/media/EqkHsrjXcAAFgGT.jpg:large)
American Society of Nephrology on X: "Stopping Renin-Angiotensin System Inhibitors in Patients with Advanced #CKD and Risk of Adverse Outcomes https://t.co/vT7yAblwZd https://t.co/fEnirq1Wv6" / X
Multi-centre Randomised Controlled Trial of Angiotensin Converting Enzyme inhibitor (ACEi) / Angiotensin Receptor Blocker (ARB)
![Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine](https://www.cebm.net/wp-content/uploads/2020/03/ACEI-ARB-recommendations-revised.png)
Angiotensin converting enzyme (ACE) inhibitors and angiotensin receptor blockers in COVID-19 - The Centre for Evidence-Based Medicine
![ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death - ScienceDirect ACE Inhibitor/Angiotensin Receptor Blocker Use Patterns in Advanced CKD and Risk of Kidney Failure and Death - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2590059520300340-fx1.jpg)